Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
Huls G, Koornstra JJ, Kleibeuker JH. Huls G, et al. Lancet. 2003 Jul 19;362(9379):230-2. doi: 10.1016/s0140-6736(03)13915-3. Lancet. 2003. PMID: 12885487 Review.
CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.
Domanska UM, Timmer-Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, Ananias HJ, Kliphuis NM, Huls G, De Vries EG, de Jong IJ, Walenkamp AM. Domanska UM, et al. Among authors: huls g. Neoplasia. 2012 Aug;14(8):709-18. doi: 10.1593/neo.12324. Neoplasia. 2012. PMID: 22952424 Free PMC article.
Liver cell proliferation after partial hepatectomy in rats with liver metastases.
de Jong KP, Brouwers MA, Huls GA, Dam A, Bun JC, Wubbena AS, Nieuwenhuis P, Slooff MJ. de Jong KP, et al. Among authors: huls ga. Anal Quant Cytol Histol. 1998 Feb;20(1):59-68. Anal Quant Cytol Histol. 1998. PMID: 9513692
Aging impairs long-term hematopoietic regeneration after autologous stem cell transplantation.
Woolthuis CM, Mariani N, Verkaik-Schakel RN, Brouwers-Vos AZ, Schuringa JJ, Vellenga E, de Wolf JT, Huls G. Woolthuis CM, et al. Among authors: huls g. Biol Blood Marrow Transplant. 2014 Jun;20(6):865-71. doi: 10.1016/j.bbmt.2014.03.001. Epub 2014 Mar 7. Biol Blood Marrow Transplant. 2014. PMID: 24607555
Paradoxical down-regulation of p16 mRNA with advancing age in acute myeloid leukemia.
de Jonge HJ, Woolthuis CM, de Bont ES, Huls G. de Jonge HJ, et al. Among authors: huls g. Aging (Albany NY). 2009 Oct 23;1(11):949-53. doi: 10.18632/aging.100096. Aging (Albany NY). 2009. PMID: 20157576 Free PMC article.
AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance.
de Jonge HJ, de Bont ES, Valk PJ, Schuringa JJ, Kies M, Woolthuis CM, Delwel R, Veeger NJ, Vellenga E, Löwenberg B, Huls G. de Jonge HJ, et al. Among authors: huls g. Blood. 2009 Oct 1;114(14):2869-77. doi: 10.1182/blood-2009-03-212688. Epub 2009 Aug 10. Blood. 2009. PMID: 19667402
Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.
Huls G, Mulder AB, Rosati S, van de Loosdrecht AA, Vellenga E, de Wolf JT. Huls G, et al. Blood. 2010 Jul 15;116(2):180-2. doi: 10.1182/blood-2010-01-263087. Epub 2010 Mar 1. Blood. 2010. PMID: 20194893
A review on CXCR4/CXCL12 axis in oncology: no place to hide.
Domanska UM, Kruizinga RC, Nagengast WB, Timmer-Bosscha H, Huls G, de Vries EG, Walenkamp AM. Domanska UM, et al. Among authors: huls g. Eur J Cancer. 2013 Jan;49(1):219-30. doi: 10.1016/j.ejca.2012.05.005. Epub 2012 Jun 9. Eur J Cancer. 2013. PMID: 22683307 Review.
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts.
van der Helm LH, Veeger NJ, Kooy Mv, Beeker A, de Weerdt O, de Groot M, Alhan C, Hoogendoorn M, Laterveer L, van de Loosdrecht AA, Koedam J, Vellenga E, Huls G. van der Helm LH, et al. Among authors: huls g. Leuk Res. 2013 Aug;37(8):877-82. doi: 10.1016/j.leukres.2013.03.022. Epub 2013 Apr 28. Leuk Res. 2013. PMID: 23628552
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability.
ten Cate B, Bremer E, de Bruyn M, Bijma T, Samplonius D, Schwemmlein M, Huls G, Fey G, Helfrich W. ten Cate B, et al. Among authors: huls g. Leukemia. 2009 Aug;23(8):1389-97. doi: 10.1038/leu.2009.34. Epub 2009 Mar 5. Leukemia. 2009. PMID: 19262596
133 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page